PRQR Stock Summary and Trading Ideas (Proqr Therapeutics N.V. - | NASDAQ:PRQR)

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

Proqr Therapeutics N.V. - trades on the NASDAQ stock market under the symbol PRQR.

As of April 17, 2024, PRQR stock price declined to $1.90 with 197,837 million shares trading.

PRQR has a beta of 1.07, meaning it tends to be more sensitive to market movements. PRQR has a correlation of 0.05 to the broad based SPY ETF.

PRQR has a market cap of $135.73 million. This is considered a Micro Cap stock.

In the last 3 years, PRQR stock traded as high as $9.09 and as low as $.53.

The top ETF exchange traded funds that PRQR belongs to (by Net Assets): AVDS.

PRQR has underperformed the market in the last year with a price return of -18.1% while the SPY ETF gained +22.5%. PRQR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -33.3% and -10.6%, respectively, while the SPY returned +6.3% and -3.6%, respectively.

PRQR support price is $1.91 and resistance is $2.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRQR stock will trade within this expected range on the day.